Barrett M, Bakker B, Breitling R. Metabolomic systems biology of trypanosomes. Parasitology. 2010;137:1285-90 pubmed publisher
..Here we discuss recent developments in metabolomic analysis, from the perspective of trypanosome research, highlighting remaining challenges and the most promising areas for future research. ..
Barrett M, Fairlamb A. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol Today. 1999;15:136-40 pubmed
..Here, Mike Barrett and Alan Fairlamb outline the mechanism underlying this crossresistance, which appears to arise as a result of alterations in an unusual adenosine transporter involved in the uptake of these drugs. ..
Barrett M, Gilbert I. Perspectives for new drugs against trypanosomiasis and leishmaniasis. Curr Top Med Chem. 2002;2:471-82 pubmed
..Therefore we also discuss approaches to designing molecules that can specifically cross the plasma membrane of African trypanosomes via unusual nutrient transporters. ..
Barrett M. The rise and fall of sleeping sickness. Lancet. 2006;367:1377-8 pubmed
Barrett M, Boykin D, Brun R, Tidwell R. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol. 2007;152:1155-71 pubmed
..Finally we report on new initiatives that might allow progress to be made in developing new and satisfactory drugs for this terrible disease...